Overview
BHC market data
Price History
BHC price chart
Valuation & Profitability
- P/E (TTM)
- 14.87 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $0.42 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.49 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -11.5% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $6.10 – $11.97 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $3.3B · P/B 12.58 · P/S 0.22.
Company News
Why Bausch Health Companies Stock Skyrocketed by Almost 40% Last MonthThe Motley Fool · Aug 10, 2026, 9:15 PM
Bausch Health Companies Raises FY2026 Sales Guidance from $10.670B-$10.920B to $10.790B-$11.040B vs $10.773B EstBenzinga · Jul 29, 2026, 8:13 PM
8-K filing — Bausch Health Companies Inc. (BHC)SEC EDGAR · Jul 29, 2026, 8:11 PM
Bausch Health Companies Q2 Adj. EPS $1.26 Beats $1.04 Estimate, Sales $2.852B Beat $2.661B EstimateBenzinga · Jul 29, 2026, 8:09 PM
Bausch Health Companies Q2 Adj. EPS $1.26 Beats $1.06 Estimate, Sales $2.852B Beat $2.679B EstimateBenzinga · Jul 29, 2026, 8:07 PM
Bausch Health's Bausch Health, Canada Announces PrELIDEL Cream Listed Under Alberta's Public Drug PlanBenzinga · Jul 28, 2026, 12:11 PM
Bausch Health Announces Quebec Provincial Listing Of Prokedi For Treatment Of Schizophrenia In AdultsBenzinga · Jul 6, 2026, 11:25 AM
Bausch Health, Canada, Completes Negotiations With pan-Canadian Pharmaceutical Alliance Resulting In LOI For PrOKEDI 75mg And 100mg, Long-Acting Injectable Antipsychotic Agent For Schizophrenia TreatmentBenzinga · Jun 9, 2026, 12:15 PM
Bausch Health And Solta Medical Announce Thermage Awarded AAA Well-Known Trademark Certification By China Trademark AssociationBenzinga · May 28, 2026, 8:43 PM
Third Point Sells Position In Alibaba Group; Bausch Health Companies; Brookfield Corporation; Casey's General Stores; Chipotle Mexican Grill; Comfort Systems USA; Constellation Energy; CoStar Group; CSX Corporation; Danaher Corporation; Kenvue; LPL Financial; Microsoft Corporation; PG&E Corporation; Progressive Corporation; Rocket Companies; Spotify Technology; Taiwan Semiconductor Manufacturing Company; Thermo Fisher Scientific; Vistra Corp.; Wix.com.Benzinga · May 15, 2026, 8:32 PM